| Walking program reduces elevated cholesterol in women postmenopause. | |
| | |
MedLine Citation:
|
PMID: 7489529 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To examine the effect of a moderate exercise regimen on total serum cholesterol, triglyceride, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), body composition and cardiovascular fitness (VO2 max) in mildly hyperlipidemic women, postmenopause. DESIGN: Randomized assignment to walking (n = 24) or control (n = 16) groups. SETTING: Community based intervention. PARTICIPANTS: Over 300 volunteers were screened to obtain the sample of 40 eligible women. Participants were mildly hyperlipidemic, postmenopause (mean age 62.0 +/- 5.7 years), sedentary, nonsmokers and not on hormone replacement therapy. Results are reported for the 25 subjects (15 walkers, 10 controls) who completed the study. INTERVENTION: Exercisers walked an average of 54.3 +/- 7.7 mins/day, 4.9 +/- 1.7 days/week, at an intensity of 54% maximum heart rate reserve, for six months. Participants were counselled not to change their diets. MAIN RESULTS: Total serum cholesterol, triglyceride, total serum cholesterol: HDL-C ratio, weight and fat mass decreased significantly in the walkers compared with the controls (P < 0.05), as did body mass index (P < 0.01). Walking resulted in a significant increase in VO2 max (P < 0.01). Changes in serum lipids were significantly related to changes in body fat, but not to change in aerobic fitness. There were no changes in dietary intake. CONCLUSIONS: A moderate intensity exercise program induces favourable alterations in total serum cholesterol and other atherogenic indices in hyperlipidemic women postmenopause, and these changes are related more to loss of body fat than to increased fitness level. |
| | |
Authors:
|
A E Ready; D T Drinkwater; J Ducas; D W Fitzpatrick; D G Brereton; S C Oades |
Related Documents
:
|
17631989 - Is there a better marker of cardiovascular risk than ldl cholesterol? apolipoproteins b... 21042169 - Association of high-density lipoprotein cholesterol with coronary heart disease risk ac... 6177959 - The emerging problem of plasma lipid changes during antihypertensive therapy. 3902379 - Comparative study of bezafibrate and fenofibrate in patients with primary hyperlipoprot... 6573839 - Lipid fractions in primary hyperparathyroidism before and after surgical cure. 3605049 - Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular ri... 537989 - Effect of l-dopa on the ovary of aged hens. 16002819 - The ala54thr polymorphism of the fatty acid-binding protein 2 gene is associated with a... 9052589 - Longitudinal changes in the relationship between body mass index and percent body fat i... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The Canadian journal of cardiology Volume: 11 ISSN: 0828-282X ISO Abbreviation: Can J Cardiol Publication Date: 1995 Nov |
Date Detail:
|
Created Date: 1996-01-04 Completed Date: 1996-01-04 Revised Date: 2008-04-09 |
Medline Journal Info:
|
Nlm Unique ID: 8510280 Medline TA: Can J Cardiol Country: CANADA |
Other Details:
|
Languages: eng Pagination: 905-12 Citation Subset: IM |
Affiliation:
|
Health, Leisure and Human Performance Research Institute, Faculty of Medicine, University of Manitoba, Winnipeg. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Body Mass Index Cholesterol / blood* Cholesterol, HDL / blood Cholesterol, LDL / blood Energy Metabolism Female Humans Middle Aged Postmenopause* Triglycerides / blood Walking* |
| Chemical | |
Reg. No./Substance:
|
0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Triglycerides; 57-88-5/Cholesterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparison of the diagnostic yield of Holter versus transtelephonic monitoring.
Next Document: Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension....